Combining sporting events, socialization, and awareness campaigns has always been a great way to involve more people in supporting a cause. Whether it’s running a marathon, completing a workout, or doing cross-country biking, injecting an element of fun into supporting a serious disease has become…
One of the major concerns of cystic fibrosis (CF) patients worldwide is their dangerous predisposition to lung infections. Because of difficult to manage mucous build-up in their airways, incidences of viral and bacterial respiratory infections can become life-threatening — especially if it is an overgrowth of…
Vertex Pharmaceuticals will be presenting 15 abstracts at the 28th Annual North American Cystic Fibrosis Conference (NACFC) held in Atlanta from October 9-11. Each abstract is from Vertex’s cystic fibrosis research and development program. Data will primarily be related to TRAFFIC and TRANSPORT clinical trials, which were phase…
In the wake of Robin Williams’ recent untimely death, the comedy world took another hit last Thursday, September 4th, when Melissa Rivers announced that she had made the unfortunate decision to take her comatose mother and international comic icon, Joan Rivers, off life support. After more than 5 years of…
New research out of Germany has made an important discovery that is shedding light on what causes Cystic Fibrosis patients to experience an impaired immune response with the disease. The research, recently published in the Journal of Molecular Medicine, entitled, “Decreased Expression of HLA-DQ and -DR…
One of the most anticipated and largest international summits of pulmonology, the European Respiratory Society’s (ERS) International Congress, is scheduled to take place on September 6-10, 2014. During this event, Insmed Incorporated will present data on their latest advancements in inhalation modalities for respiratory diseases. This year’s…
A new study, entitled, “Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs,” conducted at the University of Liverpool’s Institute of Infection and Global Health, UK, published in Nature Communications, and led by the group of the Professors Aras Kadioglu and Craig…
Sildenafil, antioxidants, and gene therapy for cystic fibrosis treatment are part of an arsenal of studies in progress at Medical College of Georgia at Georgia Regents University. At the heart of the action is Dr. Ryan A. Harris, clinical exercise physiologist at the Georgia Prevention Institute at the college.
A 23-year-old engineering student at the University of Queensland, in Australia, was granted the Young Innovator of the Year award for creating an app for children suffering from cystic fibrosis. Pepster is the app that works as a game in which children with respiratory problems due to the disease can…
In light of the news that almost 50% of cystic fibrosis patients are infected with Aspergillus mold, health leaders are reminding patients that it is important to limit exposure to agents that can cause infection for…
Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.
Get regular updates to your inbox.